TBTimothy Bracewell-Milnes

Timothy Bracewell-Milnes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Timothy Bracewell-Milnes has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    First-trimester content and quality of pregnancy apps available in the UK: a staged evaluation

    by Stephanie Gorgievska, Rebecca Gorgievska, Dehao Wu, Nan Jiang, Timothy Bracewell-Milnes, Meen-Yau Thum, James Nicopoullos

    OBJECTIVE: To evaluate first-trimester clinical content, quality, functionality, and visible privacy and security features of freely available pregnancy applications (apps) in the United Kingdom.METHODS: A three-stage pre-defined pregnancy app evaluation was conducted. Stage 1: Pregnancy apps were identified via Google Search, ChatGPT, the Apple App Store, and Google Play. 507 apps were identified and 72 met inclusion criteria. Stage 2: A researcher-developed, 65-item First Trimester Content Checklist, mapped to NICE, NHS and RCOG guidance, was applied to all 72 apps which were then categorised as Tier A (≥75%), B (55–74%), C (35–54%), or D (<35%) depending on their Percentage Coverage Score. Stage 3: Apps meeting Tier A or B underwent evaluation using the Mobile App Rating Scale (MARS), the IMS Institute for Healthcare Informatics Functionality Framework, and a researcher-developed Privacy and Security Checklist.RESULTS: Median first-trimester content coverage across the 72 apps was low at 18.1% (IQR 10.8–32.5). Most apps (n=56, 77.8%) were classified as Tier D and only six (8.3%) achieved Tier A/B. Median domain coverage was highest for Symptoms & Red Flags (27.8%) and lowest for Inclusivity (0%; IQR 0–7.1%). Among the six highest-scoring apps, MARS scores ranged from 3.52 to 4.59, IMS scores from 4 to 8 of 11, and privacy and security scores from 8 to 9 of 11.CONCLUSIONS: Most freely available UK pregnancy apps provided limited first trimester information, and important gaps remained even among the highest-scoring apps, particularly in inclusivity. As the first trimester is a period of limited clinical contact and high information need, the availability of poorly regulated pregnancy apps may expose patients to unsafe guidance or incorrect information. These findings highlight the need for improved regulation of pregnancy apps.

  • Open Access

    The Clinical Application of Platelet-Rich Plasma in the Female Reproductive System: A Narrative Review

    by Saaliha Vali, Srdjan Saso, Timothy Bracewell Milnes, James Nicopoullos, Meen-Yau Thum, James Richard Smith, Benjamin P. Jones

    Platelet-rich plasma is an autologous plasma containing platelets prepared from fresh whole blood drawn from a peripheral vein. Through processing, it can be prepared to contain supraphysiologic levels of platelets at three to five times greater than the level of normal plasma. PRP has been explored both in vivo and ex vivo in the human endometrium model in its ability to harness the intrinsic regenerative capacity of the endometrium. Intrauterine autologous PRP infusions have been shown to increase endometrial thickness and reduce the rate of intrauterine adhesions. In the setting of recurrent implantation failure, intrauterine infusion of PRP has been shown to increase clinical pregnancy rate. PRP also appears to hold a potential role in select patients with premature ovarian insufficiency, poor ovarian responders and in improving outcomes following frozen–thawed transplantation of autologous ovarian tissue. Further studies are required to explore the potential role of PRP in reproductive medicine further, to help standardise PRP protocols and evaluate which routes of administration are most effective.


  • Open Access

    Exploring the knowledge, attitudes, and perceptions of women of reproductive age towards fertility and elective oocyte cryopreservation for age-related fertility decline in the UK: a cross-sectional survey

    by L S Kasaven, A Mitra, P Ostrysz, E Theodorou, S Murugesu, J Yazbek, T Bracewell-Milnes, J Ben Nagi, B P Jones, S Saso

    What are the knowledge, perceptions and attitudes towards fertility and elective oocyte cryopreservation (OC) for age-related fertility decline (ARFD) in women in the UK? Awareness of OC for ARFD has reportedly improved compared to studies carried out almost a decade ago, but inconsistencies in knowledge remain regarding the rate of miscarriage amongst specific age groups, the financial costs and optimal age to undergo OC for ARFD. The age of first-time motherhood has increased amongst western societies, with many women of reproductive age underestimating the impact of age on fertility. Further understanding of women’s awareness of their fertility, the options available to preserve it and the barriers for seeking treatment earlier are required in order to prevent the risk of involuntary childlessness. A hyperlink to a cross-sectional survey was posted on social media (Instagram) between 25 February 2021 and 11 March 2021. Women from the general population aged 18–50 years were invited to complete the survey. In total, 5482 women fulfilled the inclusion criteria and completed the survey. The mean age of participants was 35.0 years (SD 10.25; range 16–52). Three quarters (74.1%; n = 4055) disagreed or strongly disagreed they felt well informed regarding the options available to preserve their fertility, in case of a health-related problem or ARFD. The majority overestimated the risk of miscarriage in women aged ≥30 years old, with 14.5% correctly answering 20%, but underestimated the risks in women ≥40, as 20.1% correctly answered 40–50%. Three quarters (73.2%; n = 4007) reported an awareness of OC for ARFD and 65.8% (n = 3605) reported that they would consider undergoing the procedure. The number of women who considered OC for ARFD across age groups were as follows: 18–25 (8.3%; n = 300), 26–30 (35.8%; n = 1289), 31–35 (45.9%; n = 1654), 36–40 (9.6%; n = 347), 41–45 (0.3%; n = 13), and 46–50 (0.1%; n = 2). The majority of women (81.3%; n = 4443) underestimated the cost of a single cycle of OC for ARFD (<£5000). Furthermore, 10.4% (n = 566) believed a single cycle would be adequate enough to retrieve sufficient oocytes for cryopreservation. Approximately 11.0% (n = 599) believed OC for ARFD may pose significant health risks and affect future fertility. Less than half agreed or strongly agreed that the lack of awareness regarding OC for ARFD has impacted the likelihood of pursuing this method of fertility preservation further (41.4%; n = 2259). Results from cross-sectional studies are limited as interpretations made are merely associations and not of causal relationships. The online nature of participant recruitment is subject to selection bias, considering women with access to social media are often from higher socioeconomic and education backgrounds, thus limiting generalizability of the findings. Further education regarding the financial costs and optimal age to undergo elective OC to increase the chances of successful livebirth are required. Clinicians should encourage earlier fertility counselling to ensure that OC is deemed a preventative measure of ARFD, rather than an ultimate recourse to saving declining fertility. No funding was required for this article. There are no conflicts of interests to declare. N/A.


  • Open Access

    Social egg freezing: Motivations, treatment experiences and the impact of Covid‐19 – a single‐center experience

    by Sughashini Murugesu, Mikaela Maria Charalambides, Benjamin P. Jones, Srdjan Saso, Raef Faris, Jaya Parikh, James Nicopoullos, Meen‐Yau Thum, Timothy Bracewell‐Milnes

    Introduction: This study aims to assess the motivations and treatment experiences of women undergoing social egg freezing and to understand the impact of the Covid‐19 pandemic.Material and methods: Between January 2011 to December 2021, 191 social egg freezing patients were recruited from the Lister Fertility Clinic, London UK. Participants completed a validated questionnaire investigating patients’ perspectives of social egg freezing. A response rate of 46.6% was achieved.Results: In all, 93.9% of women expressed concern regarding age‐related fertility decline which influenced their decision to undergo social egg freezing. The majority (89.5%) of women were not in a relationship at the time of social egg freezing and considered this a motivating factor. Also, 39.0% of participants had side effects related to treatment which affected work and social life. Participants were significantly more likely to experience side effects if they underwent multiple egg freezing cycles (χ2, p < 0.01) or if they cryopreserved oocytes during the COVID‐19 pandemic (χ2, p < 0.05). Of the women, 64.0% wished to have cryopreserved oocytes at a younger age, a view significantly more likely if older than 37 years at first social egg freezing cycle (χ2, p < 0.001). Also, 82.3% of women reported their decision to undergo social egg freezing was not delayed due to concerns regarding COVID‐19 exposure during treatment; 44.1% considered the pandemic made them more willing to undergo social egg freezing.Conclusions: Most participants did not regret their decision to undergo social egg freezing but the majority wished they had cryopreserved oocytes at a younger age. This highlights the importance of early education to optimize outcomes and patient choice. The egg freezing process can be stressful, women may have concerns around social egg freezing and unprecedented situations such as the COVID‐19 pandemic may alter treatment experience.


  • Open Access

    Fertility preservation and realignment in transgender women

    by Erna Bayar, Nicola J. Williams, Amel Alghrani, Sughashini Murugesu, Srdjan Saso, Timothy Bracewell-Milnes, Meen-Yau Thum, James Nicopoullos, Philippa Sangster, Ephia Yasmin, et al.

    Medical care for transgender people is multi-faceted and attention to individual reproductive aspirations and planning are an essential, yet often overlooked aspect of care. Given the impact of hormonal therapy and other gender affirmation procedures on reproductive function, extensive counselling and consideration of fertility preservation is recommended prior to their commencement. This review article explores the reproductive aspirations of transgender women and considers the current disparity between stated desires regarding utilisation of fertility preservation services. Current fertility preservation options and prospective treatments currently showing promise in the research arena are explored.


  • Open Access

    Age-related fertility decline: is there a role for elective ovarian tissue cryopreservation?

    by Lorraine S Kasaven, Srdjan Saso, Natalie Getreu, Helen O’nEill, Timothy Bracewell-Milnes, Fevzi Shakir, Joseph Yazbek, Meen-Yau Thum, James Nicopoullos, Jara Ben Nagi, et al.

    Age-related fertility decline (ARFD) is a prevalent concern amongst western cultures due to the increasing age of first-time motherhood. Elective oocyte and embryo cryopreservation remain the most established methods of fertility preservation, providing women the opportunity of reproductive autonomy to preserve their fertility and extend their childbearing years to prevent involuntary childlessness. Whilst ovarian cortex cryopreservation has been used to preserve reproductive potential in women for medical reasons, such as in pre- or peripubertal girls undergoing gonadotoxic chemotherapy, it has not yet been considered in the context of ARFD. As artificial reproductive technology (ART) and surgical methods of fertility preservation continue to evolve, it is a judicious time to review current evidence and consider alternative options for women wishing to delay their fertility. This article critically appraises elective oocyte cryopreservation as an option for women who use it to mitigate the risk of ARFD and introduces the prospect of elective ovarian cortex cryopreservation as an alternative.


  • Open Access

    Does egg-sharing negatively impact on the chance of the donor or recipient achieving a live birth?

    by Timothy Bracewell-Milnes, Aleena Hossain, Benjamin P. Jones, Raef Faris, Jaya Parikh, James Nicopoullos, Mark Johnson, Meen-Yau Thum

    This study aimed to discover whether egg sharing compromises the chance of donors or recipients achieving a live birth. A descriptive cohort study was performed of 4,545 fertility patients and 5,316 stimulation cycles at a London based fertility clinic between 2010 and 2019. There was no significant difference in clinical pregnancy rate (CPR) or live birth rate (LBR) between egg sharers and standard IVF patients or between egg sharing recipients and non-egg sharing recipients. Both egg sharers and their recipients had fewer oocytes and fewer day 3 embryos available for fresh embryo transfer or cryopreservation than standard IVF patients or non-egg sharing recipients. The cumulative LBR were significantly lower amongst egg sharers than standard IVF patients (p < 0.05), and significantly lower amongst egg sharing recipients than non-egg sharing recipients (p < 0.05). This study demonstrates that egg sharing does not compromise the chances of donors or their recipients achieving a live birth. However, participants may occasionally require additional ovarian stimulation cycles to conceive. With government funding for IVF treatment falling, egg sharing provides a practical option to allow more women access to IVF. Egg sharing is currently the most efficient way of maximising the use of the precious resource of human oocytes.


  • Impact of polyunsaturated fatty acid supplementation on assisted reproductive technology outcomes: a systematic review

    by Erna Bayar, Srdjan Saso, Nicolas Galazis, Benjamin Jones, Timothy Bracewell-Milnes, Mehar Chawla, Yousra Ahmed-Salim, Jara Ben Nagi

    This review explores the impact of polyunsaturated fatty acid (PUFA) supplementation in women undergoing assisted reproductive technology (ART) on reproductive outcomes. A systematic search of English peer-reviewed journals was carried out using MEDLINE, EMBASE, and the Cochrane Library to identify articles published from January 1978 to 2021. The primary outcomes assessed included pregnancy and live birth rates. Secondary outcome measures included: (i) implantation rate; (ii) fertilisation rate; (iii) number of oocytes retrieved; (iv) number of metaphase II (MII) oocytes; (v) blastocyst conversion; and (vi) embryo quality. A total of 4 randomised control trials (RCTs) met the inclusion criteria. There is a lack of high-quality research to support widespread dietary supplementation with PUFAs in women undergoing ART. Prior to its clinical recommendation, there is a need for well-designed RCTs to facilitate an in-depth understanding of PUFA supplementation in women undergoing ART.

  • Open Access

    Exploring the knowledge and attitudes of women of reproductive age from the general public towards egg donation and egg sharing: a UK-based study

    by Timothy Bracewell-Milnes, James C Holland, Benjamin P Jones, Srdjan Saso, Paula Almeida, Kate Maclaran, Julian Norman-Taylor, Dimitrios Nikolaou, Nishel M Shah, Mark Johnson, et al.

    What are the knowledge and views of UK-based women towards egg donation (ED) and egg sharing (ES)? Lacking knowledge of the practices of ED and ES could be an influential factor in donor egg shortages, rather than negative perceptions or lack of donor anonymity and financial incentives. The increasing age of women trying to conceive has led to donor egg shortages, with ED and ES failing to meet demand. Indeed, in recent years in the UK, ES numbers have fallen. This results in long waiting lists, forcing patients abroad for fertility treatment to take up cross border reproductive care. Previous research suggests a lack of knowledge of ED among members of the general public; however, no study has yet assessed knowledge or views of ES in the general public. Six hundred and thirty-five UK-based women over 18 years were voluntarily recruited from social media community groups by convenience sampling. The recruitment period was from February to April 2020. Participants completed a previously validated questionnaire regarding female fertility, ED and ES, including knowledge, perceptions and approval of the practices and relevant legislation. This included ranking key benefits and issues regarding egg sharing. The questionnaire was completed using the online Qualtrics survey software. Statistical analysis was conducted using SPSS. Regarding knowledge of ED and ES, 56.3% and 79.8%, respectively had little or no prior knowledge. Upon explanation, most approved of ED (85.8%) and ES (70.4%). A greater proportion of respondents would donate to a family member/friend (49.75%) than to an anonymous recipient (35.80%). Overall, ES was viewed less favourably than ED, with ethical and practical concerns highlighted. Women aged 18–30 years were significantly more likely to approve of egg donation practice compared to those aged >30 years (P < 0.0001). Those against ES found fears of financial coercion or negative psychological wellbeing the most concerning. About 35.8% and 49.7% would personally consider anonymous and known ED, respectively, whilst 56.7% would consider ES. Those answering in favour of egg sharing were significantly more likely to give higher benefit ratings compared to those against the practice (P < 0.001). Most agreed (55.8%) with and were not deterred to donate (60.1%) by the ‘Disclosure of Donor Identity’ legislation. Only 31.6% agreed with the compensatory cap; however, 52.7% would not be more motivated to donate by an increased cap. There were several limitations of the study, including the use of convenience sampling and the voluntary nature of participation opening the study up to sampling and participation bias. Finally, closed questions were predominantly used to allow the generation of quantitative data and statistical analysis. However, this approach prevented opinion justification and qualitative analysis, limiting the depth of conclusions drawn. To our knowledge, this is the first study to survey the general public’s knowledge and views of ED/ES using a previously validated questionnaire. The conclusion that lack of knowledge could be contributing to the current donor shortfall in the UK demonstrates that campaigns to inform women of the practices are necessary to alleviate donor oocyte shortages. No external funds were used for this study. The authors have no conflicts of interest. NA.


  • Open Access

    Pre-implantation genetic testing for aneuploidy: motivations, concerns, and perceptions in a UK population

    by Benjamin P. Jones, Timothy Bracewell-Milnes, Lorraine Kasaven, Ariadne L’hEveder, Megan Spearman, Diana Marcus, Maria Jalmbrant, Joy Green, Rabi Odia, Srdjan Saso, et al.

    Purpose: Pre-implantation genetic testing for aneuploidies (PGT-A) is a technique used as part of in vitro fertilisation to improve outcomes. Despite the upward trend in women utilising PGT-A, data on women’s motivations and concerns toward using the technology, and perceptions having undergone the process, remain scarce.Methods: This cross-sectional survey, based at a fertility clinic in the UK, utilised an electronic questionnaire to assess the motivations of women who undergo PGT-A and their perceptions and attitudes toward PGT-A after using it.Results: One hundred sixty-one women responded. The most significant motivating factors to undergo PGT-A were to improve the probability of having a baby per cycle (9.0 ± 2.1) and enhance the chance of implantation (8.8 ± 2.5). The least important motivations were reducing the number of embryos transferred per cycle (2.7 ± 3.3) and saving money by reducing the number of procedures required (4.6 ± 3.4). The most significant concerning factors identified included not having embryos to transfer (5.7 ± 3.4) and the potential for embryo damage (5.2 ± 3.3). The least concerning factors included religious (0.6 ± 1.7) or moral (1 ± 2.2) concerns. The majority of women were satisfied/very satisfied following treatment (n= 109; 68%). The proportion of those who were satisfied/very satisfied increased to 94.2% (n= 81) following a successful outcome, and reduced to 43.5% (n= 27) in those who had an unsuccessful outcome or had not undergone embryo transfer (p< 0.001).Conclusion: This study highlights that perceptions amongst women who use PGT-A are mostly positive. We also demonstrate a significant association between satisfaction and reproductive outcomes, with those who achieve a live birth reporting more positive perceptions toward PGT-A.